Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
Submitted by
admin
on November 9, 2023 - 9:53am
Source:
Motley Fool
News Tags:
Novo Nordisk
Wegovy
weightloss
Headline:
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
snippet:
Novo Nordisk's weight-loss drug Wegovy is relatively cheap with insurance.
That means its addressable market is less constrained by affordability concerns.
The company is still having a hard time manufacturing enough doses.
Do Not Allow Advertisers to Use My Personal information
